FDA Investigator Haley H Seymour
Haley H Seymour has inspections in 1 countries as of 14 Sep 2023. Haley H Seymour has collaborated with a combinined 2522 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Alberto A Viciedo,
Amalia C Himaya,
Amalia Himaya,
Amber G Wardwell,
Andrew M Barlow,
Anita Narula, PhD,
Anna Kevilag,
Anna Kwilas,
Barry Cherney, PhD,
Bichsa T Nguyen,
Bichsa T Tran,
Bo Chi, PhD,
Brien C Fox,
Byungja E Marciante,
Carla J Lundi,
Caryn M Mcnab,
CDR Ileana Barreto Pettit,
Charles Yuanchia Kuo, PhD,
Cheron M Portee,
Christina V Santos,
Daniel W Cline,
Davinna Ligons, PhD,
Dawn L Wydner,
Dawn M Mccabe,
Diane Cvan Leeuwen,
Diane L Raccasi,
Dipti Kalra,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Dorothy J Denes,
Dustin P Tran,
Dusty F Snoeberg,
Edmund F Mrak, Jr,
Ellen P Madigan,
Emily A Walters,
Erik W Koester,
Erin D Mccaffery,
Frances Namuswe, PhD,
Haley Seymour,
Haroon Vohra (NMI),
Harperd,
Hasan A Irier, PhD,
Helen B Ricalde,
Hugh M Mcclure, II,
Iris C Macinnes,
Jack Ragheb,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer Lalama,
Jennifer M Gogley,
Jessica L Pressley,
Jianming Li,
Joel Welch, PhD,
John P Mistler,
John R Myung,
Jose M Cayuela,
Julie D Bringger,
Jun Park, PhD,
Justine Tomasso,
Ka L Wong,
Karen M Montgomery (KMM),
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kent A Conforti,
Kim Lthomas Cruse,
Kimberly L Schultz,
Lance M De Souza, MBA,
Laura Fontan, MS,
Lauren E Swantko,
LCDR Debra Emerson,
Leonard H Lavi,
Linda Thai,
LT Richard A Lyght,
Marcia Britt Williams,
Marcus F Yambot,
Margaret M Sands,
Marilyn Welchenbach,
Mary Jeanet Mcgarry,
Maxyne T Lam,
Megan A Haggerty,
Melissa T Roy,
Michael P Anthony,
Michael Serrano,
Michelle A Marsh,
Michelle M Noe,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Monique C Lo,
Nicholas A Violand,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Nimmy Mathews,
Nina Yang,
Omotunde O Osunsanmi,
Peter R Lenahan,
Peter S Diak,
Rachael O Oyewole,
Ramon E Martinez,
Rebecca Rodriguez,
Richard H Penta,
Richmond K Yip,
Robert D Tollefsen,
Robert Darius,
Robert J Martin,
Roger F Zabinski,
Ronald L Koller,
Ronda Lebland,
Rozelle G Smith,
Ruth A Williams,
Salvatore N Randazzo,
Sandra S Saniga,
Sarah Arden,
Scott C Lute,
Scott Lute,
Scott R Nichols, PhD,
Sidney B Priesmeyer,
Sonia R Peterson,
Stanley Au,
Stephanie A Slater, MS,
Stephen R Souza,
Stephen T Hansen,
Steven A Brettler,
Steven Fong, MS, PhD,
Susan Krishner,
Taichun Qin, PhD,
Terri L Dodds,
Thao T Kwan,
Thao Tran,
Thao X Tran,
Thomas J Arista,
Tyanna N Hadley,
Unnee Ranjan,
Uttaniti Limchumroon (Tom),
Wayne E Seifert,
Youmin Wang,
Yumi J Hiramine,
Yvonne C Wilkes
Haley H Seymour's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2019 | FDA 483 | Aveva Drug Delivery Systems Inc. - Form 483, 2019-07-26 |
| February, 2020 | FDA 483 | BioMarin Pharmaceutical Inc. - Form 483, 2020-02-28 |
| June, 2011 | EIR | CELGENE CORPORATION - EIR, 2011-06-17 |
| February, 2020 | EIR | BioMarin Pharmaceutical Inc. - EIR, 2020-02-28 |
| July, 2018 | FDA 483 | Shire Human Genetic Therapies, Inc. - Form 483, 2018-07-25 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more